Express Press Release Distribution

Accounting
Advertising
Aerospace
Agriculture
Apparel & Fashion
Automotive
Biotech
Chemicals
Computers
Construction
Consumer Services
Defense
Education
Electronics
Energy
Entertainment
Environment
Financial
Food & Beverage
Government
Healthcare
Human Resources
Industrial
International Trade
Internet & Online
Law
Management
Marketing
Media
Non Profit
Pharmaceuticals
Real Estate
Retail
Semiconductors
Small Business
Software
Sports
Telecommunications
Transportation / Logistics
Travel

EPR Archived News

Archived News 2012
~ April
~ March
~ February
~ January

Archived News 2011
~ December
~ November
~ October
~ September
~ August
~ July
~ June
~ May
~ April
~ March
~ February
~ January

Archived News 2010
Archived News 2009
Archived News 2008
Archived News 2007
Archived News 2006
Archived News 2005
Archived News 2004

 

Reissuing pharmaceuticals in the NHS - Challenging the Chain of Trust

Released on = April 16, 2007, 4:02 am

Press Release Author = Namrata

Industry = Small Business

Press Release Summary = This report examines and questions the introduced DoH policy
to show how it may represent a significant challenge to the integrity of the Chain
of Trust

Press Release Body = Reissuing pharmaceuticals in the NHS: Challenging the Chain of
Trust

Report summary
The UK Department of Health (DoH) has introduced a key policy concerning the
reissuing of patients\' own pharmaceuticals on admission into hospital, determining
that this will save money and improve quality of care.

This report examines and questions the introduced DoH policy to show how it may
represent a significant challenge to the integrity of the Chain of Trust, which
offers protection to both manufacturers and patients.

Introduction
The long-term viability of every pharmaceutical manufacturer depends upon a
reputation for always delivering products that combine efficacy with safety.
Reliable combination of efficacy with safety secures the confidence and trust of
consumers (patients) and of the health care practioners (HCPs) responsible for
prescribing and issuing medicines. Manufacturers must therefore take every
reasonable measure to reduce the risk of any divergence from the expected
(registered) benchmarks of efficacy and safety for each individual medicine.

For more information kindly visit
http://www.bharatbook.com/general/Reissuing_pharmaceuticals_in_the_NHS_Challenging_the_Chain_of_Trust.html


Web Site = http://www.bharatbook.com

Contact Details = Bharat Book Bureau
207, Hermes Atrium,
Sector 11, Plot No.57,
PO Box.54, CBD Belapur,
Navi Mumbai - 400 614, India.
maharashtra
Phone: +91-(022)-2757 8668 / 2757 9438
Fax: +91-(022)-2757 9131
E-mail: info@bharatbook.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •